Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of a Standardized Research E-Cigarette on the Human Lung
NCT03691350Phase 1Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Sep 2018
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (4 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Changes in Cytokines at Day 71 and Changes in Cell Counts at Day 71. Started Sep 2018; status: completed.
Beyond the preview
Go deeper on NCT03691350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691350.